Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2303453rdf:typepubmed:Citationlld:pubmed
pubmed-article:2303453lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C0205107lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C0021701lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C0017963lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C1517880lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C1516144lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:2303453lifeskim:mentionsumls-concept:C1321758lld:lifeskim
pubmed-article:2303453pubmed:issue6lld:pubmed
pubmed-article:2303453pubmed:dateCreated1990-3-23lld:pubmed
pubmed-article:2303453pubmed:abstractTextThe extreme carboxyl-terminal amino acid sequence of the gamma chain of fibrinogen is involved in the binding of this adhesive protein to the platelet integrin glycoprotein (GP) IIb-IIIa, and synthetic peptides corresponding to this region inhibit fibrinogen as well as fibronectin and von Willebrand factor binding to platelets. A chemical cross-linking approach was used to characterize the interaction of a 16-amino acid fibrinogen gamma chain peptide with platelets and to localize the site of its binding to GPIIb-IIIa. This peptide became specifically cross-linked to GPIIb, and platelet stimulation selectively enhanced its cross-linking to this alpha subunit. The cross-linking reaction was specifically inhibited by fibrinogen and an Arg-Gly-Asp peptide but not by an unrelated protein or a substituted peptide. Utilizing a combination of immunochemical mapping, enzymatic and chemical digestions, and amino acid sequencing, the cross-linking site of the gamma chain peptide in GPIIb was localized to a stretch of 21 amino acids. The identified region, GPIIb 294-314, contains the second putative calcium binding domain within GPIIb. The primary structure of this region is highly conserved among alpha subunits of other integrin adhesion receptors. These results identify a discrete region of GPIIb that resides in close proximity to a ligand binding site within GPIIb-IIIa. The homologous region may be involved in the functions of other integrin receptors.lld:pubmed
pubmed-article:2303453pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2303453pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2303453pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2303453pubmed:languageenglld:pubmed
pubmed-article:2303453pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2303453pubmed:citationSubsetIMlld:pubmed
pubmed-article:2303453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2303453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2303453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2303453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2303453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2303453pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2303453pubmed:statusMEDLINElld:pubmed
pubmed-article:2303453pubmed:monthFeblld:pubmed
pubmed-article:2303453pubmed:issn0021-9258lld:pubmed
pubmed-article:2303453pubmed:authorpubmed-author:PlowE FEFlld:pubmed
pubmed-article:2303453pubmed:authorpubmed-author:GinsbergM HMHlld:pubmed
pubmed-article:2303453pubmed:authorpubmed-author:BurkeT ATAlld:pubmed
pubmed-article:2303453pubmed:authorpubmed-author:D'SouzaS ESElld:pubmed
pubmed-article:2303453pubmed:issnTypePrintlld:pubmed
pubmed-article:2303453pubmed:day25lld:pubmed
pubmed-article:2303453pubmed:volume265lld:pubmed
pubmed-article:2303453pubmed:ownerNLMlld:pubmed
pubmed-article:2303453pubmed:authorsCompleteYlld:pubmed
pubmed-article:2303453pubmed:pagination3440-6lld:pubmed
pubmed-article:2303453pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2303453pubmed:meshHeadingpubmed-meshheading:2303453-...lld:pubmed
pubmed-article:2303453pubmed:meshHeadingpubmed-meshheading:2303453-...lld:pubmed
pubmed-article:2303453pubmed:meshHeadingpubmed-meshheading:2303453-...lld:pubmed
pubmed-article:2303453pubmed:meshHeadingpubmed-meshheading:2303453-...lld:pubmed
pubmed-article:2303453pubmed:meshHeadingpubmed-meshheading:2303453-...lld:pubmed
pubmed-article:2303453pubmed:meshHeadingpubmed-meshheading:2303453-...lld:pubmed
pubmed-article:2303453pubmed:meshHeadingpubmed-meshheading:2303453-...lld:pubmed
pubmed-article:2303453pubmed:meshHeadingpubmed-meshheading:2303453-...lld:pubmed
pubmed-article:2303453pubmed:meshHeadingpubmed-meshheading:2303453-...lld:pubmed
pubmed-article:2303453pubmed:meshHeadingpubmed-meshheading:2303453-...lld:pubmed
pubmed-article:2303453pubmed:meshHeadingpubmed-meshheading:2303453-...lld:pubmed
pubmed-article:2303453pubmed:year1990lld:pubmed
pubmed-article:2303453pubmed:articleTitleThe ligand binding site of the platelet integrin receptor GPIIb-IIIa is proximal to the second calcium binding domain of its alpha subunit.lld:pubmed
pubmed-article:2303453pubmed:affiliationCommittee on Vascular Biology, Research Institute of Scripps Clinic, La Jolla, California 92037.lld:pubmed
pubmed-article:2303453pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2303453pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2303453pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2303453lld:pubmed
More...